Inozyme Pharma
Earnings Date & Report
Last updated:
Inozyme Pharma’s last earnings date was on 6 Aug 2024.
Inozyme Pharma stock Earnings report, Estimates & History
| 2020-07-24 | -1.41 | -0.46631 |
|---|---|---|
| 2020-09-03 | -1.41 | -7.57 |
| 2020-11-12 | -0.51 | -1.55 |
| 2021-03-25 | 0.55 | 1.01 |
| 2021-05-12 | -0.54 | -0.47 |
| 2021-08-11 | -0.57 | -0.53 |
| 2021-11-09 | -0.61 | -0.6 |
| 2022-03-15 | -0.73 | -0.79 |
| 2022-05-10 | -0.81 | -0.71 |
| 2022-08-15 | -0.48 | -0.38 |
| 2022-11-10 | -0.43 | -0.38 |
| 2023-03-15 | -0.45 | -0.43459 |
| 2023-05-09 | -0.44 | -0.4 |
| 2023-08-08 | -0.43 | -0.35 |
| 2023-11-07 | -0.32 | -0.29 |
| 2024-03-12 | -0.31 | -0.35 |
Estimated - a value of Apple’s earnings per share estimated by analysts based on its past and current financial statements.
Reported - a real value of Apple’s earnings per share reported by the company.
Inozyme Pharma stock earnings history by quarter
| Date | Estimated EPS | Reported EPS | Estimated revenue | Actual revenue | Earnings call | |
|---|---|---|---|---|---|---|
| 6 Aug 2024 | N/A | N/A | N/A | N/A | N/A | |
| 14 May 2024 | N/A | -$0.35 | N/A | N/A | N/A | |
| 12 Mar 2024 | Missed | -$0.31 | -$0.35 | N/A | N/A | |
| 7 Nov 2023 | Beat | -$0.32 | -$0.29 | N/A | N/A | |
| 8 Aug 2023 | Beat | -$0.43 | -$0.35 | N/A | N/A | |
| 9 May 2023 | Beat | -$0.44 | -$0.4 | N/A | N/A | |
| 15 Mar 2023 | Beat | -$0.45 | -$0.43 | N/A | N/A | |
| 10 Nov 2022 | Beat | -$0.43 | -$0.38 | N/A | N/A | |
| 15 Aug 2022 | Beat | -$0.48 | -$0.38 | N/A | N/A | |
| 10 May 2022 | Beat | -$0.81 | -$0.71 | N/A | N/A | |
| 15 Mar 2022 | Missed | -$0.73 | -$0.79 | N/A | N/A | |
| 9 Nov 2021 | Beat | -$0.61 | -$0.6 | N/A | N/A | |
| 11 Aug 2021 | Beat | -$0.57 | -$0.53 | N/A | N/A | |
| 12 May 2021 | Beat | -$0.54 | -$0.47 | N/A | N/A | |
| 25 Mar 2021 | Beat | $0.55 | $1.01 | N/A | N/A | |
| 12 Nov 2020 | Missed | -$0.51 | -$1.55 | N/A | N/A | |
| 3 Sep 2020 | Missed | -$1.41 | -$7.57 | N/A | N/A | |
| 24 Jul 2020 | Beat | -$1.41 | -$0.47 | N/A | N/A | |
| 31 Mar 2020 | N/A | N/A | -$0.51 | N/A | N/A | |
| 31 Dec 2019 | N/A | N/A | -$0.43 | N/A | N/A | |
Inozyme Pharma Earnings report FAQs
When is Inozyme Pharma's next Earnings date?
The company has not set the next earnings date yet. The latest Inozyme Pharma's earnings date was on 8 Aug 2023.
What are earnings?
Earnings are the net income of a company after all taxes and expenses have been deducted. They are the main figure for determining the price of a company's shares.
What does EPS stand for?
EPS stands for earnings per share, which is the basic measure of a company's earnings. It indicates how much money each share earned for the company.
How to calculate earnings per share?
Earnings per share (EPS) can be calculated by dividing a company's net income by the number of common shares outstanding. If the company pays preferred dividends, they are first subtracted from the company’s net income.
Formula:
What is earnings per share estimate?
Earnings estimate is analysts’ prediction of a company’s earnings value in the next quarter or fiscal year based on past and current financial statements of a company. It is an important indicator for both current and future investors.